Pfizer acknowledge the need for conflict specific packages. We believe that our leading position in the pharmaceutical domain is a strength, given the essential medicines and vaccines that we produce. Glad to review any motions that could address this matter. #LonWHO2019
We would like to work on producing a Conflict Area Special Package for Vaccine and Communicable Disease medication access. We value support from @LancetLonwho201 @GileadLon @MSFLonWHO2019
The NSAs who are campaigning for mandatory vaccinations and equal access to vaccinations to internally displaced individuals and refugees especially children under 5, pregnant women, elderly with chronic illness and immunocompromised individuals. #LonWHO19#LonWHO2019
@Portugal_LonWHO looks to write a working paper to begin preventative measures: a widespread screening and vaccination program against communicable diseases for refugees and conflict zone populations
Portugal encourages member states and NGOs to collaborate
#LonWHO2019
Pfizer can only agree. Immunisation in refugee population and especially infant under 5 is a priority. Pfizer is willing to work alongside countries to provide them with essential medicines and vaccines.
Portugal looks forward to working with the EURO block to find constructive solutions for the spread of communicable diseases in conflict zones and amongst refugee populations.
#LonWHO2019
Pfizer strongly supports motions regarding essential services and needs packages. Access to basics medicine and vaccines are the foundation of #Healthforall#LonWHO2019